Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the genetics of type 2 diabetes are poorly understood and under intense investigation in this era of precision medicine (52).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Self-citationGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Research works printed but not linked: 1
- Rewers M, Stene LC, Norris JM Chapter 11: Risk factors for type 1 diabetes. In Diabetes in America, 3rd ed Cowie CC, Casagrande SS, Menke A,, Eds. Bethesda, MD, National Institutes of Health, 2018
Cited by
Items 101–200 of 401
Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stone, S., Balasubramanyam, A., & Posey, J. E. (2024) · Diabetes Care · doi:10.2337/dci23-0038 · Cited by 27
Treatment of type 2 diabetes mellitus in the elderly – Special considerations
Gadó, K., Tabák, Á. G., Vingender, I., Domján, G., & Dörnyei, G. (2024) · Physiology International · doi:10.1556/2060.2024.00317 · Cited by 27
Apergi, K., Dimosthenopoulos, C., & Παπάνας, Ν. (2023) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346231153531 · Cited by 20
Unraveling the connection: Inflammatory markers and diabetes mellitus pathogenesis
Obeagu, E. I. (2026) · Medicine · doi:10.1097/md.0000000000047338 · Cited by 28
Wang, C., Ye, D., Xie, Z., Huang, X., Wang, Z., Shangguan, H., Zhu, W., & Wang, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s335017 · Cited by 21
Li, Z., Zhao, M., Li, J., Luo, W., Huang, J., Huang, G., Xie, Z., Xiao, Y., Huang, J., Li, X., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109729 · Cited by 17
Multiple nanotechnological approaches using natural compounds for diabetes management
Stoleru, O. A., Burlec, A. F., Mircea, C., Felea, M. G., Macovei, I., Hăncianu, M., & Corciovă, A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01376-1 · Cited by 27
Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients
Ma, B. M., Elefant, N., Tedesco, M., Bogyo, K., Vena, N., Murthy, S. B. K., Bheda, S., Yang, S. Y.-R., Tomar, N., Zhang, J. Y., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.02.021 · Cited by 20
Young-Onset Diabetes in East Asians: From Epidemiology to Precision Medicine
Chan, J. C. N., Chun Kwan, O., & Luk, A. O. Y. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1968 · Cited by 21
Standards of Care in Diabetes. The position of Diabetes Poland – 2024
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Broncel, M., Budzynski, A. Z., Cyganek, K., Cypryk, K., CYRANKA, K. M., Czupryniak, L., Dzida, G. J., et al. (2024) · Current Topics in Diabetes · doi:10.5114/ctd/183052 · Cited by 33
Singh, O., Verma, M., Dahiya, N., Senapati, S., Kakkar, R., & Kalra, S. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01676-6 · Cited by 25
Precision Medicine in Diabetes, Current Research and Future Perspectives
Franceschi, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081233 · Cited by 20
Lean type 2 diabetes: the overlooked epidemic reshaping global health
Singh, V. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02015-w · Cited by 21
Khalil, S. A., Azar, S. T., Hafidh, K., Ayad, G., & Safwat, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230731105704 · Cited by 15
Miao, X., Davoudi, M., Alitotonchi, Z., Ahmadi, E. S., Amraee, F., Alemi, A., & Afrisham, R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01581-3 · Cited by 20
Bazzazzadehgan, S., Shariat‐Madar, Z., & Mahdi, F. (2025) · Biomolecules · doi:10.3390/biom15030414 · Cited by 21
Ronald, C. W., Tam, C. H. T., Hou, Y. J., Lau, E. S. H., Ozaki, R., Lui, J. N. M., Chow, E., Kong, A. P. S., Huang, C., Ng, A. C. W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06299-x · Cited by 19
Zheng, Y., Feng, Y., Wang, Y., Kong, L., Zhou, M., Wu, M., Liu, C., Weng, H., & Wang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12015 · Cited by 16
Enabling Precision Medicine via Contemporary and Future Communication Technologies: A Survey
Chude-Okonkwo, U. A. K., Paul, B. S., & Vasilakos, A. V. (2022) · IEEE Access · doi:10.1109/access.2022.3175573 · Cited by 16
Song, Y., He, C., Jiang, Y., Yang, M., Zhao, X., Yuan, L., Zhang, W., & Xu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1132194 · Cited by 17
A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda
Narayan, K. M. V., Varghese, J. S., Beyh, Y. S., Bhattacharyya, S., Khandelwal, S., Krishnan, G. S., Siegel, K. R., Thomas, T. S., & Kurpad, A. V. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00354-5 · Cited by 20
White, S. L., Koulman, A., Ozanne, S. E., Furse, S., Poston, L., & Meek, C. L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad168 · Cited by 16
CagriSema and the link between obesity and type 2 diabetes
Apovian, C. M., & McDonnell, M. E. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01291-6 · Cited by 15
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease
Ahluwalia, T. S., Rönkkö, T., Eickhoff, M. K., Curovic, V. R., Siwy, J., Eder, S., Denicolò, S., Mayer, G. J., Mischak, H., Rossing, P. R., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.11.020 · Cited by 16
Kulkarni, D. S., Ghosh, A., Girdhari, A., Liu, S., Vance, L. A., Unruh, M., & Sarkar, J. (2023) · Natural Language Processing Journal · doi:10.1016/j.nlp.2023.100045 · Cited by 15
Chan, J. C. N., Chow, E., Kong, A. P. S., Cheung, E. Y. N., Tony, O., Lim, C. K. P., Fan, B., Tsoi, S. T. F., Fan, Y., Shi, M., et al. (2024) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2023.36 · Cited by 18
Therapeutic Interventions for Diabetes Mellitus-associated Complications
Pradhan, D., Sahu, P. K., Purohit, S., Ranajit, S. K., Acharya, B., Sangam, S., & Shrivastava, A. K. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998291870240408043837 · Cited by 19
Wu, C., Ge, Y., Zhang, X., Liu, M., Heng, C., Zhang, L., Du, Y., He, S., Shang, L., & Lang, H. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01790-0 · Cited by 16
Diabetes Awareness, Treatment, and Control among Mexico City Residents
Barquera, S., Hernández-Alcaraz, C., Jáuregui, A., Medina, C., Mendoza-Herrera, K., Pedroza-Tobías, A., Tolentino‐Mayo, L., Pineda, L. E. G., López‐Ridaura, R., & Aguilar-Salinas, C. A. (2021) · Diabetology · doi:10.3390/diabetology2010002 · Cited by 14
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes
Tomlinson, B., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1985465 · Cited by 19
The emerging role of incretins and twincretins
Chow, E., & Chan, J. C. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00607-w · Cited by 16
Grant, W. B., Anouti, F. A., Boucher, B. J., Fakhoury, H. M. A., Moukayed, M., Pilz, S., & Al‐Daghri, N. M. (2023) · Biomedicines · doi:10.3390/biomedicines11040994 · Cited by 15
Internet of Things and Big Data Analytics in Preventive Healthcare: A Synthetic Review
(2024) · doi:10.3390/electronics13183642 · Cited by 19
Moreno-Fernández, J., Sastre, J., Pinés, P. J., Calderón-Vicente, D., Gargallo, J., & Muñoz‐Rodríguez, J. R. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.03.013 · Cited by 14
Khartabil, N., & Avoundjian, A. (2025) · Genes · doi:10.3390/genes16010107 · Cited by 18
Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview
Guo, Z., & Priefer, R. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102239 · Cited by 17
Giosuè, A., Calabrese, I., Riccardi, G., Vaccaro, O., & Vitale, M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110071 · Cited by 14
Chobot, A. P., Eckert, A. J., Biester, T., Corathers, S. D., Covinhas, A., de Beaufort, C. E., Imane, Z., Kim, J. H., Malatyńska, A., Moravej, H., et al. (2023) · Pediatric Diabetes · doi:10.1155/2023/8578231 · Cited by 17
Tian, X., Wang, L., Zhong, L., Zhang, K., Ge, X., Luo, Z., Zhai, X., & Liu, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1555077 · Cited by 22
Castelblanco, E., Hernández, M., Ortega, E., Amigó, N., Real, J., Granado-Casas, M., Miñambres, I., López‐Cano, C., Lecube, A., Bermúdez-López, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109145 · Cited by 13
Precision Medicine in Type 1 Diabetes
Michalek, D. A., Önengüt-Gümüşcü, S., Repaske, D. R., & Rich, S. S. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-023-00356-x · Cited by 15
Die elektronische Diabetesakte eDA der DDG (Deutsche Diabetes Gesellschaft)
Müller‐Wieland, D., & Ickrath, M. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00746-8 · Cited by 12
Metwally, A. A., Perelman, D., Park, H., Wu, Y., Jha, A., Sharp, S. A., Celli, A., Ayhan, E. M., Abbasi, F., Gloyn, A. L., et al. (2024) · medRxiv · doi:10.1101/2024.07.20.24310737 · Cited by 12
Fritsche, A. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2016-8392 · Cited by 12
Kuß, O., Opitz, M. E., Brandstetter, L. V., Schlesinger, S., Roden, M., & Hoyer, A. (2023) · Diabetologia · doi:10.1007/s00125-023-05951-2 · Cited by 13
Molecular mechanism of HNF-1A–mediated HNF4A gene regulation and promoter-driven HNF4A-MODY diabetes
Kind, L., Molnes, J., Tjora, E., Raasakka, A., Myllykoski, M., Colclough, K., Saint‐Martin, C., Adelfalk, C., Dušátková, P., Průhová, Š., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.175278 · Cited by 16
Unveiling the Disparities in the Field of Precision Medicine: A Perspective
Morsi, M. H., Elawfi, B., ALsaad, S. A., Nazar, A., Mostafa, H. A., Awwad, S. A., Abdelwahab, M. M., Tarakhan, H., & Baghagho, E. (2025) · Health Science Reports · doi:10.1002/hsr2.71102 · Cited by 12
Unnikrishnan, R., Radha, V., & Mohan, V. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s271582 · Cited by 13
Conway, N., Bluett, M., Shields, C., Taylor, A., Wake, D. J., & Cunningham, S. G. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211005734 · Cited by 13
Göbl, C. S., Morettini, M., Salvatori, B., Alsalim, W., Kahleová, H., Åhrén, B., & Tura, A. (2022) · Nutrients · doi:10.3390/nu14020376 · Cited by 13
Transform diabetes care with precision medicine
Kannan, S., Chellappan, D. K., Kow, C. S., Ramachandram, D. S., Pandey, M., Mayuren, J., Dua, K., & Candasamy, M. (2023) · Health Science Reports · doi:10.1002/hsr2.1642 · Cited by 14
Veroniki, A. A., Seitidis, G., Stewart, L. A., Clarke, M. J., Smith, C. T., Mavridis, D., Yu, C. H. Y., Moja, L., Straus, S. E., & Tricco, A. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058034 · Cited by 12
Ronald, C. W., Xie, F., Lim, C. K. P., Lau, E. S. H., Luk, A. O. Y., Ozaki, R., Cheung, G. P. Y., Lee, H. M., Ng, A. C. W., Li, H. W., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109969 · Cited by 10
Infante, M., & Ricordi, C. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2168645 · Cited by 11
Features characterising cardiac autonomic neuropathy in diabetes using ensembled classification
Nedergaard, R. B., Scott, M., Wegeberg, A., Okdahl, T., Størling, J., Brock, B., Drewes, A. M., & Brock, C. (2023) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.06.011 · Cited by 11
Ayipo, Y. O., Chong, C. F., Abdulameed, H. T., & Mordi, M. N. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.105922 · Cited by 10
Metabolic trajectories of diabetic ketoacidosis onset described by breath analysis
Awchi, M., Singh, K. D., Brenner, S. B., Burckhardt, M., Hess, M., Zeng, J., Datta, A., Frey, U., Zumsteg, U., Szinnai, G., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1360989 · Cited by 10
Lu, B., Li, P., Crouse, A. B., Grimes, T., Might, M., Ovalle, F., & Shalev, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae516 · Cited by 13
REDONDO, M. J., Cuthbertson, D. D., Steck, A. K., Herold, K. C., Oram, R. A., Atkinson, M. A., Brusko, T. M., Parikh, H. M., Krischer, J. P., Önengüt-Gümüşcü, S., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06338-7 · Cited by 14
Cook, T. W., Wilstermann, A. M., Mitchell, J. T., Arnold, N. E., Rajasekaran, S., Bupp, C. P., & Prokop, J. W. (2023) · Biomolecules · doi:10.3390/biom13020257 · Cited by 12
One size does not fit all: an historian’s perspective on precision diabetes medicine
Tuchman, A. M. (2022) · Diabetologia · doi:10.1007/s00125-022-05660-2 · Cited by 10
Systematic Review of Treatment of Beta-Cell Monogenic DiabetesPreprint
Naylor, R. N., Patel, K. A., Kettunen, J. L. T., Männistö, J. M. E., Støy, J., Beltrand, J., Polak, M., PMDI, A., Vilsbøll, T., Greeley, S. A. W., et al. (2023) · medRxiv · doi:10.1101/2023.05.12.23289807 · Cited by 10
Zou, X., Liu, Y., & Ji, L. (2023) · Digital Health · doi:10.1177/20552076231203879 · Cited by 20
Laurindo, L. F., Laurindo, L. F., Rodrigues, V. D., Oliveira, J. D. S. C., Boaro, B. L., Araújo, A. C., Guiguer, É. L., Detregiachi, C. R. P., Catharin, V. M. C. S., Chagas, E. F. B., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1502815 · Cited by 13
Brazil nut (Bertholletia excelsa Bonpl.) in health and disease: A narrative review
Takeda, L. N., Omine, A., Laurindo, L. F., Araújo, A. C., Machado, N. M., Dias, J. A., Kavalakatt, J., Banerjee, S., Goulart, R. D. Á., Atanasov, A. G., et al. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.143425 · Cited by 9
Chen, X., Balmer, L. A., Lin, K., Cao, W., Huang, Z., Chen, X., Song, M., & Chen, Y. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00410-x · Cited by 10
Jaeger, B. C., Casanova, R., Demesie, Y. N., Stafford, J. M., Wells, B. J., & Bancks, M. P. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf250 · Cited by 10
Dina, M. A., Arshed, A., Karamat, A., Bilal, M., & Basit, M. S. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00235-7 · Cited by 21
Göbl, C., & Tura, A. (2022) · Nutrients · doi:10.3390/nu14020312 · Cited by 10
Liang, R., Long, J., Zheng, Q., Yuan, G., Chen, X., Xin, Z., Lai, F., & Liu, Y. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01627-0 · Cited by 11
Yu, H., Ho, M. M., Chau, P. H., & Fong, D. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15173 · Cited by 9
Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
Huang, Q., Zou, X., Chen, Y., Gao, L., Cai, X., Zhou, L., Gao, F., Zhou, J., Jia, W., & Ji, L. (2023) · iScience · doi:10.1016/j.isci.2023.108195 · Cited by 10
McLennan, N.-M., Hazlehurst, J., Thangaratinam, S., & Reynolds, R. M. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1046 · Cited by 13
Tunedal, K., Viola, F., Casas, B., Bolger, A. F., Nyström, F. H., Östgren, C. J., Engvall, J. E., Lundberg, P., Dyverfeldt, P., Carlhäll, C., et al. (2023) · The Journal of Physiology · doi:10.1113/jp284652 · Cited by 9
Corrao, S., & Federici, M. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02556-6 · Cited by 8
Chong, C. F., Hasnizan, N. Y. U., & Mokhtar, A. M. A. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110855 · Cited by 9
Zhang, Y., Meng, Y., Ji, L., Jianjun, W., & Fan, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1576983 · Cited by 9
Pollin, T. I., & Taylor, S. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142364 · Cited by 7
Precision medicine in diabetes—Finally some light at the end of the tunnel?
Raj, G. M., & Mathaiyan, J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14674 · Cited by 8
Nieto, J., Castillo, B., Astudillo, M., Tosur, M., Balasubramanyam, A., Pietropaolo, M., & REDONDO, M. J. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13238 · Cited by 10
The Role of Metabolomics in Personalized Medicine for Diabetes
Chowdhury, S., Faheem, S. M., Nawaz, S. S., & Siddiqui, K. (2021) · Personalized Medicine · doi:10.2217/pme-2021-0083 · Cited by 7
Moreno-Fernández, J., Sastre, J., Pinés, P. J., Calderón-Vicente, D., Gargallo, J., & Muñoz‐Rodríguez, J. R. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.12.003 · Cited by 11
Maloney, K. A., Mizerik, E. A., King, R. H., McGinnis, E. M., Perkowitz, S., Diamonstein, C. J., Schmanski, A. A., Saliganan, S., Shipper, A. G., Udler, M. S., et al. (2023) · Journal of Genetic Counseling · doi:10.1002/jgc4.1744 · Cited by 7
Here’s to 100 Years of Insulin and Science—and More to Come!
Riddle, M. C. (2021) · Diabetes Care · doi:10.2337/dci21-0013 · Cited by 7
A Systematic Review of the use of Precision Diagnostics in Monogenic DiabetesPreprint
Murphy, R., Colclough, K., Pollin, T., Ikle, J. M., Svalastoga, P., Maloney, K. A., Saint-Martin, C., Molnes, J., Misra, S., Aukrust, I., et al. (2023) · medRxiv · doi:10.1101/2023.04.15.23288269 · Cited by 3
Kim, N. N., Wessells, H., DiSanto, M. E., Ferrini, M. G., Lin, G., Pfaus, J. G., Priviero, F. B. M., Yong, P. J., & Podlasek, C. A. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf032 · Cited by 6
Toledo, F. G. S., Li, Y., Wang, F., Bellin, M. D., Brand, R. E., Cusi, K. J., Fisher, W. P., Kudva, Y. C., Park, W. G., Saeed, Z. I., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06543-y · Cited by 6
Yang, Q., Liu, X., Zhang, T., Zhao, X., & 肖小河 (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s591764 · Cited by 10
Rapid Point-of-Care Test for Determination of C-Peptide Levels
Rao, P. V., Bean, E., Nair-Schaef, D., Chen, S., Kazmierczak, S. C., Roberts, C. T., & Nagalla, S. R. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821995557 · Cited by 6
Shin, M., Yang, Y., Kang, J. H., & Jin, H. Y. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s466734 · Cited by 9
Liu, W. X., Hu, X., Fang, Y., Hong, S., Zhu, Y., Zhang, M., Gong, S., Wang, X., Lin, C., Zhang, R., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16068 · Cited by 6
Pacini, G., Åhrén, B., Göbl, C. S., & Tura, A. (2022) · Biomedicines · doi:10.3390/biomedicines10051060 · Cited by 6
Implementation of Precision Genetic Approaches for Type 1 and 2 Diabetes
Ronald, C. W., & Chan, J. C. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_5 · Cited by 6
Lü, B., Sun, J., Chen, L., Song, X., Deng, Y., Dong, Y., Dong, J., Du, P., Ge, J., Guo, Y., et al. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.01.003 · Cited by 7
Optimizing maturity‐onset diabetes of the young detection in a pediatric diabetes population
Menon, S., REFAEY, A. K., Guffey, D., Balasubramanyam, A., REDONDO, M. J., & Tosur, M. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13329 · Cited by 7
Morieri, M. L., Pipino, C., & Doria, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091402 · Cited by 7
Dennis, J., Young, K., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., Henley, W., Holman, R. R., Sattar, N. A., Pearson, E. R., et al. (2021) · medRxiv · doi:10.1101/2021.11.11.21265959 · Cited by 6
Hatmal, M. M., Abuyaman, O., Al-Hatamleh, M. A. I., Tayyem, H., Olaimat, A. N., Mussa, A., Aolymat, I., Abu-Awad, A., Odeh, M. M., & Qawaqzeh, R. A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06720-y · Cited by 10
Chan, J. C. N., Deerochanawong, C., Khunti, K., Hassanein, M. M., & Mohan, V. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113173 · Cited by 10
Li, Z., Liu, S., Ho, J. C., Narayan, K. M. V., Ali, M. K., & Varghese, J. S. (2026) · Diabetologia · doi:10.1007/s00125-026-06687-5 · Cited by 8
Metadata
- Authors
- Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., Philipson, L., McElvaine, A. T., Cefalu, W. T., Rich, S. S., & Franks, P. W.
- Affiliations
- Columbia University Irving Medical Center (US)
- American Diabetes Association (US)
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- University of Exeter (GB)
- Harvard University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Centre for Human Genetics (GB)
- Trinity College Dublin (IE)
- Colorado School of Public Health (US)
- University of Dundee (GB)
- University of Chicago (US)
- Duke University (US)
- University of Virginia (US)
- Corresponding author
- Franks, Paul W.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-11
- Volume
- 43
- Issue
- 7
- Pages
- 1617-1635
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7305007
- OpenAlex
- W3036199105
- Cited by
- 400
- References
- 136
- Citations by year
- 2026: 50 · 2025: 57 · 2024: 74 · 2023: 92 · 2022: 72 · 2021: 47 · 2020: 8
- FWCI
- 41.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Funders
- American Diabetes Association (1-15-ACE-26)
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Regeneron Pharmaceuticals
- Wellcome Trust (212259, 098381, 098395, 098395/Z/12/Z, 203141, 102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219, NF-SI-0617-10090)
- European Commission (115317, 115881, 875534, 098381)
- Lunds Universitet
- Novo Nordisk
- Vetenskapsrådet
- Universitetet i Bergen
- Servier
- National Institutes of Health (5r21ai142483-02, DK26687, UL1TR001873)
- Genentech
- Medical Research Council (MR/K005707/1, MR/T032014/1)
- National Institute of Allergy and Infectious Diseases (R21-AI142483)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, R01DK104942, 212259, R01DK052431, R01DK122586, U01DK105535, DP3DK111906, DK 26687, DK104351, R01DK104351, DK122586, 098381, 203141, P30DK026687, U54DK118612, P30DK020595, DK-52431)
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
- University of Colorado School of Medicine, Anschutz Medical Campus
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- precision medicine, diabetes mellitus, precision diagnostics, precision therapy, monogenic diabetes, diabetes prevention, diabetes treatment, implementation barriers, personalized medicine, diabetes phenotypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Europe, Financial Management, Health Plan Implementation, Humans, Practice Patterns, Physicians', Quality of Life, Societies, Medical, United States, Evidence-Based Medicine, Consensus, Biomedical Research, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.